nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—CHRM2—type 1 diabetes mellitus	0.515	1	CbGaD
Procainamide—BCHE—Ramipril—type 1 diabetes mellitus	0.326	1	CbGbCtD
Procainamide—SCN11A—peripheral nervous system—type 1 diabetes mellitus	0.00763	0.139	CbGeAlD
Procainamide—Antinuclear antibody positive—Ramipril—type 1 diabetes mellitus	0.00678	0.18	CcSEcCtD
Procainamide—SCN11A—nerve—type 1 diabetes mellitus	0.00594	0.109	CbGeAlD
Procainamide—SCN8A—peripheral nervous system—type 1 diabetes mellitus	0.00578	0.106	CbGeAlD
Procainamide—SCN8A—nerve—type 1 diabetes mellitus	0.00451	0.0824	CbGeAlD
Procainamide—SCN10A—peripheral nervous system—type 1 diabetes mellitus	0.00387	0.0707	CbGeAlD
Procainamide—SCN10A—nerve—type 1 diabetes mellitus	0.00301	0.0551	CbGeAlD
Procainamide—SCN7A—cardiovascular system—type 1 diabetes mellitus	0.00177	0.0324	CbGeAlD
Procainamide—DNMT1—retina—type 1 diabetes mellitus	0.00161	0.0294	CbGeAlD
Procainamide—Vasculitis—Ramipril—type 1 diabetes mellitus	0.00158	0.0418	CcSEcCtD
Procainamide—SCN9A—nephron tubule—type 1 diabetes mellitus	0.00154	0.0282	CbGeAlD
Procainamide—ACHE—islet of Langerhans—type 1 diabetes mellitus	0.00153	0.0279	CbGeAlD
Procainamide—Sunitinib—TYK2—type 1 diabetes mellitus	0.00144	0.593	CrCbGaD
Procainamide—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.0014	0.0371	CcSEcCtD
Procainamide—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.00138	0.0365	CcSEcCtD
Procainamide—DNMT1—cardiovascular system—type 1 diabetes mellitus	0.00136	0.0249	CbGeAlD
Procainamide—SLC22A2—nephron tubule—type 1 diabetes mellitus	0.00126	0.0231	CbGeAlD
Procainamide—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00124	0.033	CcSEcCtD
Procainamide—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.00124	0.0328	CcSEcCtD
Procainamide—SCN4A—kidney—type 1 diabetes mellitus	0.00121	0.0221	CbGeAlD
Procainamide—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.00118	0.0313	CcSEcCtD
Procainamide—SCN10A—nephron tubule—type 1 diabetes mellitus	0.00118	0.0215	CbGeAlD
Procainamide—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00117	0.0312	CcSEcCtD
Procainamide—Arthritis—Ramipril—type 1 diabetes mellitus	0.00115	0.0305	CcSEcCtD
Procainamide—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.00114	0.0304	CcSEcCtD
Procainamide—DNMT1—lymphoid tissue—type 1 diabetes mellitus	0.00114	0.0209	CbGeAlD
Procainamide—SLC22A2—kidney—type 1 diabetes mellitus	0.00111	0.0203	CbGeAlD
Procainamide—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.00102	0.0271	CcSEcCtD
Procainamide—SCN5A—cardiovascular system—type 1 diabetes mellitus	0.00096	0.0175	CbGeAlD
Procainamide—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.000956	0.0254	CcSEcCtD
Procainamide—SCN3A—kidney—type 1 diabetes mellitus	0.000942	0.0172	CbGeAlD
Procainamide—SLC22A4—nephron tubule—type 1 diabetes mellitus	0.000938	0.0172	CbGeAlD
Procainamide—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.000926	0.0246	CcSEcCtD
Procainamide—Neutropenia—Ramipril—type 1 diabetes mellitus	0.000903	0.024	CcSEcCtD
Procainamide—SCN10A—lymphoid tissue—type 1 diabetes mellitus	0.000887	0.0162	CbGeAlD
Procainamide—Renal failure—Ramipril—type 1 diabetes mellitus	0.000846	0.0225	CcSEcCtD
Procainamide—SLC22A4—kidney—type 1 diabetes mellitus	0.000825	0.0151	CbGeAlD
Procainamide—CHRM2—cardiovascular system—type 1 diabetes mellitus	0.000817	0.0149	CbGeAlD
Procainamide—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.000803	0.0213	CcSEcCtD
Procainamide—SLC22A1—kidney—type 1 diabetes mellitus	0.000785	0.0144	CbGeAlD
Procainamide—SLC22A3—kidney—type 1 diabetes mellitus	0.00075	0.0137	CbGeAlD
Procainamide—Lidocaine—EGFR—type 1 diabetes mellitus	0.000742	0.306	CrCbGaD
Procainamide—Flushing—Ramipril—type 1 diabetes mellitus	0.000717	0.019	CcSEcCtD
Procainamide—SLC22A5—retina—type 1 diabetes mellitus	0.000659	0.0121	CbGeAlD
Procainamide—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000659	0.0175	CcSEcCtD
Procainamide—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.000624	0.0166	CcSEcCtD
Procainamide—SLC22A5—nephron tubule—type 1 diabetes mellitus	0.000621	0.0114	CbGeAlD
Procainamide—Angioedema—Ramipril—type 1 diabetes mellitus	0.000615	0.0163	CcSEcCtD
Procainamide—Malaise—Ramipril—type 1 diabetes mellitus	0.000607	0.0161	CcSEcCtD
Procainamide—BCHE—nephron tubule—type 1 diabetes mellitus	0.000605	0.0111	CbGeAlD
Procainamide—Convulsion—Ramipril—type 1 diabetes mellitus	0.000583	0.0155	CcSEcCtD
Procainamide—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000573	0.0152	CcSEcCtD
Procainamide—Myalgia—Ramipril—type 1 diabetes mellitus	0.000573	0.0152	CcSEcCtD
Procainamide—Discomfort—Ramipril—type 1 diabetes mellitus	0.000566	0.015	CcSEcCtD
Procainamide—Confusional state—Ramipril—type 1 diabetes mellitus	0.000554	0.0147	CcSEcCtD
Procainamide—SLC22A5—kidney—type 1 diabetes mellitus	0.000546	0.00998	CbGeAlD
Procainamide—BCHE—cardiovascular system—type 1 diabetes mellitus	0.000543	0.00993	CbGeAlD
Procainamide—Shock—Ramipril—type 1 diabetes mellitus	0.00054	0.0143	CcSEcCtD
Procainamide—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000538	0.0143	CcSEcCtD
Procainamide—Anorexia—Ramipril—type 1 diabetes mellitus	0.000523	0.0139	CcSEcCtD
Procainamide—Hypotension—Ramipril—type 1 diabetes mellitus	0.000513	0.0136	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.0005	0.0133	CcSEcCtD
Procainamide—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000477	0.0127	CcSEcCtD
Procainamide—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000452	0.012	CcSEcCtD
Procainamide—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000449	0.0119	CcSEcCtD
Procainamide—Urticaria—Ramipril—type 1 diabetes mellitus	0.000436	0.0116	CcSEcCtD
Procainamide—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000434	0.0115	CcSEcCtD
Procainamide—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000434	0.0115	CcSEcCtD
Procainamide—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000405	0.0107	CcSEcCtD
Procainamide—Asthenia—Ramipril—type 1 diabetes mellitus	0.000394	0.0105	CcSEcCtD
Procainamide—Pruritus—Ramipril—type 1 diabetes mellitus	0.000388	0.0103	CcSEcCtD
Procainamide—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000376	0.00997	CcSEcCtD
Procainamide—Dizziness—Ramipril—type 1 diabetes mellitus	0.000363	0.00964	CcSEcCtD
Procainamide—CYP2D6—kidney—type 1 diabetes mellitus	0.000352	0.00644	CbGeAlD
Procainamide—Vomiting—Ramipril—type 1 diabetes mellitus	0.000349	0.00926	CcSEcCtD
Procainamide—Nausea—Ramipril—type 1 diabetes mellitus	0.000326	0.00865	CcSEcCtD
Procainamide—Probenecid—ALB—type 1 diabetes mellitus	0.000246	0.101	CrCbGaD
Procainamide—SCN9A—Developmental Biology—TYK2—type 1 diabetes mellitus	4.85e-05	0.000751	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	4.85e-05	0.000751	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—INS—type 1 diabetes mellitus	4.81e-05	0.000745	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—INS—type 1 diabetes mellitus	4.81e-05	0.000745	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ABCC8—type 1 diabetes mellitus	4.73e-05	0.000732	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—EGFR—type 1 diabetes mellitus	4.68e-05	0.000725	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—VDR—type 1 diabetes mellitus	4.67e-05	0.000723	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—IGFBP1—type 1 diabetes mellitus	4.66e-05	0.000721	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	4.66e-05	0.000721	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TYK2—type 1 diabetes mellitus	4.64e-05	0.000719	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	4.61e-05	0.000713	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—STAT3—type 1 diabetes mellitus	4.59e-05	0.000711	CbGpPWpGaD
Procainamide—ACHE—Metabolism—HBA2—type 1 diabetes mellitus	4.57e-05	0.000707	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	4.52e-05	0.0007	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—IL6—type 1 diabetes mellitus	4.5e-05	0.000696	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	4.46e-05	0.000691	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—TNF—type 1 diabetes mellitus	4.46e-05	0.000691	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TYK2—type 1 diabetes mellitus	4.46e-05	0.00069	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TYK2—type 1 diabetes mellitus	4.46e-05	0.00069	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	4.43e-05	0.000685	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—IAPP—type 1 diabetes mellitus	4.35e-05	0.000674	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—EGFR—type 1 diabetes mellitus	4.33e-05	0.00067	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TYK2—type 1 diabetes mellitus	4.3e-05	0.000666	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TYK2—type 1 diabetes mellitus	4.3e-05	0.000666	CbGpPWpGaD
Procainamide—ACHE—Metabolism—G6PC2—type 1 diabetes mellitus	4.29e-05	0.000665	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—TYK2—type 1 diabetes mellitus	4.24e-05	0.000656	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—STAT3—type 1 diabetes mellitus	4.2e-05	0.00065	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—EGFR—type 1 diabetes mellitus	4.18e-05	0.000646	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	4.17e-05	0.000646	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	4.16e-05	0.000644	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—EGFR—type 1 diabetes mellitus	4.14e-05	0.000641	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	4.13e-05	0.000639	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—IL6—type 1 diabetes mellitus	4.11e-05	0.000637	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	4.09e-05	0.000633	CbGpPWpGaD
Procainamide—BCHE—Metabolism—HBA2—type 1 diabetes mellitus	4.07e-05	0.000631	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	4.07e-05	0.00063	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—EGFR—type 1 diabetes mellitus	3.98e-05	0.000616	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—EGFR—type 1 diabetes mellitus	3.98e-05	0.000616	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—TNF—type 1 diabetes mellitus	3.98e-05	0.000616	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—EGFR—type 1 diabetes mellitus	3.83e-05	0.000594	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—EGFR—type 1 diabetes mellitus	3.83e-05	0.000594	CbGpPWpGaD
Procainamide—BCHE—Metabolism—G6PC2—type 1 diabetes mellitus	3.83e-05	0.000593	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—SST—type 1 diabetes mellitus	3.82e-05	0.000592	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—EGFR—type 1 diabetes mellitus	3.82e-05	0.000591	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	3.81e-05	0.000589	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—CDK4—type 1 diabetes mellitus	3.8e-05	0.000588	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	3.78e-05	0.000585	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—KCNJ11—type 1 diabetes mellitus	3.74e-05	0.000579	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—ACE—type 1 diabetes mellitus	3.74e-05	0.000578	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ABCC8—type 1 diabetes mellitus	3.72e-05	0.000577	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	3.72e-05	0.000576	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—HBA2—type 1 diabetes mellitus	3.64e-05	0.000563	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—TNF—type 1 diabetes mellitus	3.64e-05	0.000563	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—IL6—type 1 diabetes mellitus	3.6e-05	0.000557	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—GCG—type 1 diabetes mellitus	3.53e-05	0.000546	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—G6PC2—type 1 diabetes mellitus	3.42e-05	0.00053	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—GCG—type 1 diabetes mellitus	3.41e-05	0.000528	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—STAT3—type 1 diabetes mellitus	3.4e-05	0.000526	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HBA2—type 1 diabetes mellitus	3.39e-05	0.000525	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—INS—type 1 diabetes mellitus	3.38e-05	0.000524	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	3.37e-05	0.000522	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—ACE—type 1 diabetes mellitus	3.33e-05	0.000516	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—IL6—type 1 diabetes mellitus	3.33e-05	0.000515	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ABCC8—type 1 diabetes mellitus	3.32e-05	0.000514	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	3.27e-05	0.000507	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	3.27e-05	0.000506	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—STAT3—type 1 diabetes mellitus	3.25e-05	0.000503	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	3.23e-05	0.000501	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—IL6—type 1 diabetes mellitus	3.21e-05	0.000497	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—G6PC2—type 1 diabetes mellitus	3.19e-05	0.000494	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—IL6—type 1 diabetes mellitus	3.18e-05	0.000493	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	3.18e-05	0.000492	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ITPR3—type 1 diabetes mellitus	3.16e-05	0.000489	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GAL—type 1 diabetes mellitus	3.15e-05	0.000488	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—GCG—type 1 diabetes mellitus	3.15e-05	0.000487	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	3.14e-05	0.000486	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	3.12e-05	0.000484	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—STAT3—type 1 diabetes mellitus	3.12e-05	0.000483	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—STAT3—type 1 diabetes mellitus	3.12e-05	0.000483	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	3.12e-05	0.000483	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—EGFR—type 1 diabetes mellitus	3.09e-05	0.000478	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—IL6—type 1 diabetes mellitus	3.06e-05	0.000473	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—IL6—type 1 diabetes mellitus	3.06e-05	0.000473	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TYK2—type 1 diabetes mellitus	3.02e-05	0.000468	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—STAT3—type 1 diabetes mellitus	3.01e-05	0.000466	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—STAT3—type 1 diabetes mellitus	3.01e-05	0.000466	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—IGF2—type 1 diabetes mellitus	2.99e-05	0.000462	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	2.98e-05	0.000461	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—HBA1—type 1 diabetes mellitus	2.97e-05	0.00046	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ABCC8—type 1 diabetes mellitus	2.97e-05	0.000459	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—EGFR—type 1 diabetes mellitus	2.95e-05	0.000457	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—APOC3—type 1 diabetes mellitus	2.95e-05	0.000457	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—IL6—type 1 diabetes mellitus	2.95e-05	0.000456	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—IL6—type 1 diabetes mellitus	2.95e-05	0.000456	CbGpPWpGaD
Procainamide—ACHE—Metabolism—KCNJ11—type 1 diabetes mellitus	2.94e-05	0.000456	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TNF—type 1 diabetes mellitus	2.94e-05	0.000455	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—IL6—type 1 diabetes mellitus	2.93e-05	0.000454	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	2.92e-05	0.000453	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GSTT1—type 1 diabetes mellitus	2.9e-05	0.000449	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GAL—type 1 diabetes mellitus	2.86e-05	0.000443	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—EGFR—type 1 diabetes mellitus	2.84e-05	0.000439	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—EGFR—type 1 diabetes mellitus	2.84e-05	0.000439	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCL20—type 1 diabetes mellitus	2.83e-05	0.000438	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCL11—type 1 diabetes mellitus	2.83e-05	0.000438	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TNF—type 1 diabetes mellitus	2.81e-05	0.000436	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ABCC8—type 1 diabetes mellitus	2.77e-05	0.000428	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—EGFR—type 1 diabetes mellitus	2.74e-05	0.000424	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—EGFR—type 1 diabetes mellitus	2.74e-05	0.000424	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TNF—type 1 diabetes mellitus	2.7e-05	0.000418	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TNF—type 1 diabetes mellitus	2.7e-05	0.000418	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—EGFR—type 1 diabetes mellitus	2.7e-05	0.000417	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—IGF2—type 1 diabetes mellitus	2.66e-05	0.000413	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	2.63e-05	0.000407	CbGpPWpGaD
Procainamide—BCHE—Metabolism—KCNJ11—type 1 diabetes mellitus	2.63e-05	0.000407	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TNF—type 1 diabetes mellitus	2.61e-05	0.000404	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TNF—type 1 diabetes mellitus	2.61e-05	0.000404	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—type 1 diabetes mellitus	2.59e-05	0.000401	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	2.54e-05	0.000393	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	2.53e-05	0.000392	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ITPR3—type 1 diabetes mellitus	2.48e-05	0.000385	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CCR5—type 1 diabetes mellitus	2.46e-05	0.000381	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	2.46e-05	0.000381	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	2.39e-05	0.00037	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	2.38e-05	0.000368	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—IL6—type 1 diabetes mellitus	2.37e-05	0.000367	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—KCNJ11—type 1 diabetes mellitus	2.35e-05	0.000363	CbGpPWpGaD
Procainamide—ACHE—Metabolism—HBA1—type 1 diabetes mellitus	2.34e-05	0.000362	CbGpPWpGaD
Procainamide—ACHE—Metabolism—APOC3—type 1 diabetes mellitus	2.32e-05	0.00036	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GCG—type 1 diabetes mellitus	2.31e-05	0.000358	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GSTT1—type 1 diabetes mellitus	2.28e-05	0.000353	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—IL6—type 1 diabetes mellitus	2.27e-05	0.000351	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IAPP—type 1 diabetes mellitus	2.23e-05	0.000346	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ITPR3—type 1 diabetes mellitus	2.22e-05	0.000343	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—KCNJ11—type 1 diabetes mellitus	2.19e-05	0.000338	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—IL6—type 1 diabetes mellitus	2.18e-05	0.000338	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—IL6—type 1 diabetes mellitus	2.18e-05	0.000338	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—SST—type 1 diabetes mellitus	2.16e-05	0.000334	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	2.15e-05	0.000333	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—STAT3—type 1 diabetes mellitus	2.12e-05	0.000328	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	2.1e-05	0.000326	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—IL6—type 1 diabetes mellitus	2.1e-05	0.000326	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—IL6—type 1 diabetes mellitus	2.1e-05	0.000326	CbGpPWpGaD
Procainamide—BCHE—Metabolism—HBA1—type 1 diabetes mellitus	2.09e-05	0.000323	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOC3—type 1 diabetes mellitus	2.07e-05	0.000321	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—IL6—type 1 diabetes mellitus	2.07e-05	0.000321	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GSTT1—type 1 diabetes mellitus	2.04e-05	0.000315	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—INS—type 1 diabetes mellitus	1.98e-05	0.000307	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ITPR3—type 1 diabetes mellitus	1.98e-05	0.000306	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—SST—type 1 diabetes mellitus	1.96e-05	0.000304	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CAT—type 1 diabetes mellitus	1.96e-05	0.000303	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	1.95e-05	0.000302	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GCG—type 1 diabetes mellitus	1.93e-05	0.000298	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—EGFR—type 1 diabetes mellitus	1.92e-05	0.000298	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	1.92e-05	0.000297	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—IGF1—type 1 diabetes mellitus	1.92e-05	0.000297	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.88e-05	0.000291	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	1.87e-05	0.00029	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—HBA1—type 1 diabetes mellitus	1.86e-05	0.000288	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	1.85e-05	0.000287	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOC3—type 1 diabetes mellitus	1.85e-05	0.000287	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ITPR3—type 1 diabetes mellitus	1.85e-05	0.000286	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TNF—type 1 diabetes mellitus	1.83e-05	0.000284	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GCG—type 1 diabetes mellitus	1.82e-05	0.000282	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GSTT1—type 1 diabetes mellitus	1.82e-05	0.000282	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	1.8e-05	0.000279	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	1.8e-05	0.000278	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—INS—type 1 diabetes mellitus	1.77e-05	0.000274	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	1.76e-05	0.000273	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GCG—type 1 diabetes mellitus	1.75e-05	0.000271	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HBA1—type 1 diabetes mellitus	1.74e-05	0.000269	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOC3—type 1 diabetes mellitus	1.73e-05	0.000267	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—IGF1—type 1 diabetes mellitus	1.71e-05	0.000265	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GSTT1—type 1 diabetes mellitus	1.69e-05	0.000262	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GAL—type 1 diabetes mellitus	1.69e-05	0.000262	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	1.68e-05	0.000261	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL11—type 1 diabetes mellitus	1.67e-05	0.000259	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL20—type 1 diabetes mellitus	1.67e-05	0.000259	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—VAV1—type 1 diabetes mellitus	1.63e-05	0.000253	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	1.63e-05	0.000252	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GCG—type 1 diabetes mellitus	1.62e-05	0.000251	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.59e-05	0.000247	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CAT—type 1 diabetes mellitus	1.54e-05	0.000238	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	1.53e-05	0.000236	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.49e-05	0.00023	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—IL6—type 1 diabetes mellitus	1.48e-05	0.000229	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GCG—type 1 diabetes mellitus	1.45e-05	0.000224	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ITPR3—type 1 diabetes mellitus	1.41e-05	0.000218	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	1.39e-05	0.000216	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CAT—type 1 diabetes mellitus	1.37e-05	0.000213	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	1.37e-05	0.000212	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GCG—type 1 diabetes mellitus	1.35e-05	0.000209	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SH2B3—type 1 diabetes mellitus	1.33e-05	0.000206	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOC3—type 1 diabetes mellitus	1.32e-05	0.000204	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IAPP—type 1 diabetes mellitus	1.32e-05	0.000204	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—INS—type 1 diabetes mellitus	1.3e-05	0.000201	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.26e-05	0.000196	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.25e-05	0.000193	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CAT—type 1 diabetes mellitus	1.23e-05	0.00019	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	1.21e-05	0.000187	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ALB—type 1 diabetes mellitus	1.19e-05	0.000184	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SST—type 1 diabetes mellitus	1.16e-05	0.000179	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.15e-05	0.000179	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CAT—type 1 diabetes mellitus	1.14e-05	0.000177	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—NOS3—type 1 diabetes mellitus	1.14e-05	0.000176	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GCG—type 1 diabetes mellitus	1.03e-05	0.00016	CbGpPWpGaD
Procainamide—ACHE—Metabolism—INS—type 1 diabetes mellitus	1.02e-05	0.000158	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	1.02e-05	0.000158	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	9.94e-06	0.000154	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VAV1—type 1 diabetes mellitus	9.66e-06	0.00015	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	9.63e-06	0.000149	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	9.59e-06	0.000148	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	9.53e-06	0.000148	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALB—type 1 diabetes mellitus	9.37e-06	0.000145	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	9.36e-06	0.000145	CbGpPWpGaD
Procainamide—BCHE—Metabolism—INS—type 1 diabetes mellitus	9.12e-06	0.000141	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NOS3—type 1 diabetes mellitus	8.96e-06	0.000139	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	8.78e-06	0.000136	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF2—type 1 diabetes mellitus	8.74e-06	0.000135	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CD86—type 1 diabetes mellitus	8.42e-06	0.00013	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALB—type 1 diabetes mellitus	8.36e-06	0.000129	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—INS—type 1 diabetes mellitus	8.14e-06	0.000126	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.04e-06	0.000125	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NOS3—type 1 diabetes mellitus	7.99e-06	0.000124	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—E2F1—type 1 diabetes mellitus	7.99e-06	0.000124	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.59e-06	0.000118	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—INS—type 1 diabetes mellitus	7.59e-06	0.000117	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.47e-06	0.000116	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALB—type 1 diabetes mellitus	7.46e-06	0.000116	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	7.46e-06	0.000115	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.36e-06	0.000114	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.3e-06	0.000113	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NOS3—type 1 diabetes mellitus	7.14e-06	0.000111	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALB—type 1 diabetes mellitus	6.96e-06	0.000108	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NOS3—type 1 diabetes mellitus	6.65e-06	0.000103	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	6.31e-06	9.78e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CD80—type 1 diabetes mellitus	6.14e-06	9.51e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—INS—type 1 diabetes mellitus	5.8e-06	8.99e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.61e-06	8.69e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.59e-06	8.65e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.19e-06	8.03e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.09e-06	7.88e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.32e-06	6.69e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL2—type 1 diabetes mellitus	4.31e-06	6.68e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.29e-06	6.65e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	4.19e-06	6.49e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	3.84e-06	5.95e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	3.68e-06	5.69e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.63e-06	5.62e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.3e-06	5.11e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.54e-06	3.93e-05	CbGpPWpGaD
